Liberty Mutual Group Asset Management Inc. Novo Nordisk A S Transaction History

Liberty Mutual Group Asset Management Inc.

  • $660 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$41.54 - $47.25 $845,837 - $962,104
-20,362 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$46.76 - $51.24 $367,440 - $402,643
-7,858 Reduced 27.85%
20,362 $960,000
Q1 2018

May 09, 2018
SELL
$48.49 - $58.14 $178,443 - $213,955
-3,680 Reduced 11.54%
28,220 $1.39 Million
Q4 2017

Feb 12, 2018
BUY
$47.53 - $53.73 $1.15 Million - $1.29 Million
24,100 Added 308.97%
31,900 $1.71 Million
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $320,970 - $383,916
7,800
7,800 $376,000

Others Institutions Holding NVO

# of Institutions
1,879
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email